Status:
COMPLETED
Clinicopathologic Findings for Macular Disease
Lead Sponsor:
Hallym University Medical Center
Conditions:
Macular Disease
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
this study is to analyze and compare the ultrastructure of the retinal and vitreous plane of the epiretinal membrane and internal limiting membrane removed during macular surgery and to evaluate relat...
Detailed Description
prospective, interventional study and includes patients who underwent vitrectomy,peeling of an epiretinal membrane and internal limiting membrane excision with or without intraoperative intraocular IC...
Eligibility Criteria
Inclusion
- patients who underwent vitrectomy,peeling of an idiopathic MEM and ILM excision with or without intraoperative intraocular ICG injectio
Exclusion
- the presence of macular hole or lamellar macular hole previous vitreoretinal surgery the presence of any other macular pathologic features potentially interfering with histologic results (such as diabetic retinopathy or age-related macular degeneration).
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00994227
Start Date
May 1 2009
End Date
June 1 2010
Last Update
April 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
JiWon Lim
Seoul, South Korea